Sign inJoin waitlistJoin the waitlist

DD

Davey Daniel

Physician · OneOncology

Credentials: · · · · ·

History

OneOncology
Present

Research

Durvalumab after Chemoradiotherapy in Stage III Non-Small-Cell Lung Cancer
New England Journal of Medicine · 2017 · 3,824 citations
Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC
New England Journal of Medicine · 2018 · 2,311 citations
Atezolizumab in combination with carboplatin plus nab-paclitaxel chemotherapy compared with chemotherapy alone as first-line treatment for metastatic non-squamous non-small-cell…
The Lancet Oncology · 2019 · 1,417 citations

DS
David Spigel
16 papers
Scott Antonia
10 papers
Augusto Villegas
9 papers
JH
John Hainsworth
6 papers
David Waterhouse
5 papers
Jhanelle Gray
5 papers
PD
Phillip Dennis
5 papers
Alberto Chiappori
4 papers
HB
Howard Burris
4 papers
LS
Lee Schwartzberg
4 papers
Maen Hussein
4 papers
MM
Michael Mccleod
4 papers

Clinical trials

Safety and Efficacy of Talactoferrin in Addition to Standard Chemotherapy in Patients With Non-small Cell Lung Cancer
Site PI · Unknown · Phase 3
Agennix
2009–2016